Lantern Pharma
LTRN
Lantern Pharma (LTRN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.57
- EPS estimate
- −$0.38
- EPS surprise
- −50.00%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 14, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | −$0.38 | −$0.57 | −50.00% | $0.00 | SEC |
| Q1 2026 | May 15, 2026 | −$0.36 | −$0.30 | +16.67% | $0.00 | SEC |
| Q4 2025 | Mar 30, 2026 | −$0.46 | −$0.36 | +21.74% | $0.00 | SEC |
| Q3 2025 | Nov 12, 2025 | −$0.47 | −$0.39 | +17.02% | $0.00 | SEC |
| Q2 2025 | Aug 13, 2025 | −$0.44 | −$0.40 | +9.09% | $0.00 | SEC |
| Q1 2025 | May 15, 2025 | −$0.49 | −$0.42 | +14.29% | $0.00 | SEC |
| Q4 2024 | Mar 27, 2025 | −$0.51 | −$0.54 | −5.88% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.56 | −$0.42 | +25.00% | $0.00 | SEC |
| Q2 2024 | Aug 8, 2024 | −$0.55 | −$0.46 | +16.36% | $0.00 | SEC |
| Q1 2024 | May 9, 2024 | −$0.43 | −$0.51 | −18.60% | $0.00 | SEC |
| Q4 2023 | Mar 18, 2024 | −$0.40 | −$0.39 | +2.50% | $0.00 | SEC |
| Q3 2023 | Nov 8, 2023 | −$0.48 | −$0.29 | +40.00% | $0.00 | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.43 | −$0.44 | −1.55% | $0.00 | SEC |
| Q1 2023 | May 9, 2023 | −$0.48 | −$0.36 | +25.00% | $0.00 | SEC |
| Q4 2022 | Mar 20, 2023 | −$0.47 | −$0.31 | +34.04% | $0.00 | SEC |
| Q3 2022 | Nov 7, 2022 | −$0.48 | −$0.21 | +56.25% | $0.00 | — |
| Q2 2022 | Aug 8, 2022 | −$0.52 | −$0.41 | +21.15% | $0.00 | — |
| Q1 2022 | May 3, 2022 | −$0.29 | −$0.38 | −31.03% | $0.00 | — |
| Q4 2021 | Mar 10, 2022 | −$0.40 | −$0.31 | +23.13% | $0.00 | SEC |
| Q3 2021 | Nov 1, 2021 | −$0.27 | −$0.36 | −34.98% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Lantern Pharma (LTRN) last report earnings?
Lantern Pharma last reported on Aug 14, 2026, covering fiscal Q2 2026.
Did LTRN beat earnings estimates?
No. Lantern Pharma reported EPS of −$0.57 for Q2 2026 against a −$0.38 estimate — a 50.00% miss.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.